<?xml version="1.0" encoding="UTF-8"?>
<p>In summary, MMAb 10G12 was specific for HAdV-7 and displayed good stability. In future work, we will explore whether MMAb 10G12 can provide protection against HAdV-7 
 <italic>in vivo</italic>, and if so, MMAb may be further humanized for use as a therapeutic agent.
</p>
